TSE advisory committee
This article was originally published in The Gray Sheet
Executive Summary
Upcoming Feb. 20 Transmissible Spongiform Encephalopathies advisory committee meeting will address implementation of the final guidance on preventive measures to reduce the possible risk of transmission of CJD and vCJD disease by blood and blood products and the document's ramifications on the blood supply. The guidance was issued in January 2002. Also on the agenda is a discussion of labeling claims for TSE agent clearance in plasma derivatives...